Maintenance of erectile function after photoselective vaporization of the prostate for obstructive benign prostatic hyperplasia

Journal of Sexual Medicine

Volumn 5, Issue 11, 2008, Pages 2669-2671

  Kavoussi, Parviz K ^a   Hermans, Michael R ^a  

^a SCOTT AND WHITE MEMORIAL HOSPITAL   (United States)

Author keywords

Benign Prostatic Hyperplasia; Erectile Function; Greenlight; Photoselective Vaporization of the Prostate

Indexed keywords

AGED; ARTICLE; CONTROLLED STUDY; ERECTILE DYSFUNCTION; FOLLOW UP; HUMAN; INDWELLING CATHETER; INTERMITTENT CATHETERIZATION; MAJOR CLINICAL STUDY; MALE; PENIS ERECTION; PHOTOSELECTIVE VAPORIZATION OF THE PROSTATE; POSTOPERATIVE PERIOD; PREOPERATIVE CARE; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROSTATE HYPERTROPHY; PROSTATE SURGERY; SCORING SYSTEM; SEXUAL FUNCTION; SEXUAL HEALTH INVENTORY FOR MEN;

EID: 55849131741     PISSN: 17436095     EISSN: 17436109     Source Type: Journal    
DOI: 10.1111/j.1743-6109.2008.00978.x     Document Type: Article

References (12)

1. Te AE. The PVPLprocedure for BPH: Long-term outcomes: laser's efficacy seems similar to that of TURP, with comparable long-term durability. Urol Times 2007;17:40-2.
2. Murtagh J, Foerster V. Photoselective vaporization for benign prostatic hyperplasia. Issues Emerg Health Technol 2006;95:1-4.
3. Kaplan SA. Expanding the role of photoselective vaporization of the prostate. Rev Urol 2006;8(3 suppl):S3-8.
4. Sarica K, Alkan E, Luleci H, Taski AI. Photoselective vaporization of the enlarged prostate with KTP laser: Long-term results in 240 patients. J Endourol 2005;19:1199-2002.
5. Taher A. Erectile dysfunction after transurethral resection of the prostate: Incidence and risk factors. World J Urol 2004;22:457-60.
6. Paick JS, Um JM, Ku JH. Influence of high-power potassium-titanyl-phosphate photoselective vaporization of the prostate on erectile function: A short-term follow-up study. J Sex Med 2007;4:1701-7.
7. Costabile RA, Steers WD. How can we best characterize the relationship between erectile dysfunction and benign prostatic hyperplasia? J Sex Med 2006;3:676-81.
8. Antunes AA, Srougi M, Dall'oglio MF, Vicentini F, Paranhos M, Freire GC. The role of BPH, lower urinary tract symptoms, and PSA levels on erectile function of Brazilian men who undergo prostate cancer screening. J Sex Med 2008;5:1702-7.
9. Chitale S, Collins R, Hull S, Smith E, Irving S. Is the current practice providing an integrated approach to the management of LUTS and ED in primary care? An audit and literature review. J Sex Med 2007;4:1713-25.
10. Bhojani N, Perrotte P, Jeldres C, Suardi N, Hutterer G, Shariat SF, Karakiewicz PI. The effect of comorbidities and socioeconomic status on sexual and urinary function in men undergoing prostate cancer screening. J Sex Med 2008;5:668-76.
11. El-Sakka AI. Lower urinary tract symptoms in patients with erectile dysfunction: Analysis of risk factors. J Sex Med 2006;3:144-9.
12. Mulhall JP, Guhring P, Parker M, Hopps C. Assessment of the impact of sildenafil citrate on lower urinary tract symptoms in men with erectile dysfunction. J Sex Med 2006;3:662-7.